SNHG16 is overexpressed in a variety of cancers (Gong et al., 2020), such as neuroblastoma (Xu et al., 2020), lung cancer (Xia et al., 2021), thyroid cancer (Wen et al., 2019), and breast cancer (Du et al., 2020). The gene discussed is SNHG16; the disease is thyroid cancer.